Opella, the consumer health business of French giant Sanofi (EPA: SAN, NASDAQ: SNY), held a collaboration press conference with JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), in Beijing this week. The collaboration aims to jointly enhance public awareness of fatty liver through activities such as doctor-patient education and disease popularization.
Collaboration Details
The partnership between Opella and JD Healthcare integrates the professional resources and health solutions of Opella with the digital service platform of JD Healthcare. This integration is designed to accelerate the diagnosis and treatment of fatty liver, improve people’s weight management abilities, and enhance overall health levels.
Strategic Objectives
By combining their respective strengths, Opella and JD Healthcare are committed to addressing the growing public health challenge of fatty liver in China. The initiative will leverage digital tools and professional medical knowledge to increase disease awareness, improve early diagnosis, and promote effective management strategies for patients with fatty liver.-Fineline Info & Tech
Leave a Reply